SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak Co. is trending due to its ongoing transformation from a legacy print business into high-margin sectors like pharmaceuticals and advanced materials, with the community highlighting the imminent launch of its pharma division in 2025. Discussions also focus on the company's debt reduction plans using pension assets, potential trade policy tailwinds, and undervalued real estate holdings. Investors are closely watching for news and contracts related to Kodak's pharmaceutical ventures, with some speculating about partnerships and a potential meme stock resurgence.

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is trending as investors discuss its potential in decentralized data storage, especially in light of AI and Web3 projects. Community members are actively comparing it to other cryptocurrencies like ZEC and DASH, speculating on price targets, and highlighting its real-world utility, such as competing with Amazon AWS. The conversation also mentions Filecoin's use cases with Solana and NASA.

COTI is a fast and light confidentiality layer on Ethereum. Powered by the breakthrough cryptographic protocol Garbled Circuits and secured by Ethereum, COTI introduces the most advanced and compliant solution for data protection on the public blockchain. Paving the way for the next wave of Web3 innovation and adoption, COTI unlocks a whole new world of use cases, including confidential transactions, Artificial Intelligence, DeFi, decentralized identification, and more.

COTI

COTI is trending as the community discusses its potential in the privacy and security sector, with comparisons being made to established coins like ZEC and its growing ecosystem. Bullish sentiment seems to be building, with some anticipating mainnet and new partnerships to serve as catalysts. Community members are also talking about accumulation and COTI's AI-driven trading potential.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy ($CHWY) is trending as traders discuss its upcoming earnings and potential breakout, with some highlighting Mizuho's recent upgrade and a price target of $50. Bullish sentiment seems to be building due to strong Autoship sales and recurring revenue, even amid discussions of competition and market volatility. Some are speculating on a run to the $40-$50 range, while others are wary, citing past earnings disappointments and broader market concerns.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is seeing increased attention, with community members discussing its potential for significant gains and comparing it to other cryptocurrencies. Recent news and partnerships are fueling optimism, though some traders remain skeptical, pointing to past performance. Overall, the community is weighing the long-term potential of Quant against short-term market fluctuations.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is experiencing increased volatility, with community members pointing to AI sector movement and potential bullish reversals as catalysts. The conversation highlights speculation about the reasons behind the pump, with some users discussing staking and potential price targets. Overall, the community seems optimistic, suggesting it might be "NEARvember" and highlighting its potential within the AI narrative.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Chardan Healthcare

Chardan Healthcare (CHAC) is trending due to its merger with Xanadu, a quantum computing firm, generating excitement within the community. Discussions revolve around Xanadu's technology, including its PennyLane software and potential partnerships, as well as comparisons to other quantum computing companies. Some are also looking into CHAC's rights offerings and their relationship to the stock.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending amid speculation about a potential breakup, with discussions focusing on whether this could unlock shareholder value or if debt concerns remain. The company's attractive dividend yield is also a key point, with some viewing it as a safe, inflation hedge play, while others express skepticism about long-term growth.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

ICP is trending due to renewed community excitement around its technology as a decentralized internet solution and potential to challenge centralized cloud services. Discussions highlight its unique architecture, interoperability with other blockchains, and recent developments like Caffeine AI, driving speculation about future growth and adoption. Some traders are drawing comparisons to ZCash's previous price movements, while others caution against shorting and emphasize long-term potential.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

NMAX is trending due to options activity and speculation around its potential for high ROI, with traders discussing strategies involving January 2027 call options. The community is weighing positive catalysts, such as Newsmax's recent deal to make its channel available in numerous hotels, against concerns about dilution and the stock's overall performance. Broader market context includes its association with other Trump-related stocks and the media sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRISPR Therapeutics AG (CRSP) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a -2.56% change from its previous close.

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $9.00 by Analysts at Wedbush

Wedbush lowered their price target on shares of CRISPR Therapeutics from $13.00 to $9.00 and set an "outperform" rating on the stock in a report on Wednesday...

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

VRTX's new drugs deliver a mixed Q3 performance. Alyftrek sales surge. Journavx and Casgevy lag expectations but show promise.

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

VRTX tops Q3 earnings and revenue estimates on strong Trikafta and Alyftrek sales, but shares slip as Casgevy sales disappoint.

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

RXRX gears up for Q3 results as it refocuses its pipeline and collaboration-driven revenue strategy.

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?

CRISPR Therapeutics is likely to witness an earnings beat as Casgevy sales climb and new CAR-T and in-vivo programs advance.

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.

CRISPR Therapeutics AG (CRSP) Stock Moves -2.51%: What You Should Know

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $62.56, representing a -2.51% change from its previous close.

Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy?

Urogen Pharma (URGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

Strong Trikafta/Kaftrio demand, along with contributions from Alyftrek, Casgevy and Journavx, may have helped VRTX outperform in the third quarter.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$55.56
Prev Close	$56.61
Open	$53.61
Dividend Yield	0.00%
50-Day Moving Average	$62.93
Beta	1.61
Avg. Volume	2.64M
PE Ratio	-10.16

52-Week High	$78.48
52-Week Low	$30.04
Market Capitalization	$5.01B
EPS (Annual)	-$4.34
Price to Book	2.85
Revenue Per Employee	$94,946.57
Enterprise Value/EBITDA	N/A

CRSP
CRISPR Therapeutics AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRSP News

CRSPCRISPR Therapeutics AG